Alopecia After Switch to Tenofovir Alafenamide in 6 African American Women

No cases of tenofovir alafenamide (TAF)–induced alopecia have been reported in the literature. We describe 6 cases of hair loss in African American female patients after switching to TAF and aim to raise awareness about this potential adverse effect of TAF, which could predominate in certain patient...

Descripción completa

Detalles Bibliográficos
Autores principales: El Zein, Said, Tabaja, Hussam, Kanj, Amjad, Richmond, Deborah, Veltman, Jennifer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6641785/
https://www.ncbi.nlm.nih.gov/pubmed/31341928
http://dx.doi.org/10.1093/ofid/ofz278
Descripción
Sumario:No cases of tenofovir alafenamide (TAF)–induced alopecia have been reported in the literature. We describe 6 cases of hair loss in African American female patients after switching to TAF and aim to raise awareness about this potential adverse effect of TAF, which could predominate in certain patient populations.

Ejemplares similares